- Home
- SEED vs ERNA Comparison
SEED vs ERNA Comparison
Compare SEED & ERNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SEED
- ERNA
- Stock Information
- Founded
- SEED 1997
- ERNA 2018
- Country
- SEED China
- ERNA United States
- Employees
- SEED N/A
- ERNA N/A
- Industry
- SEED Farming/Seeds/Milling
- ERNA Biotechnology: Pharmaceutical Preparations
- Sector
- SEED Consumer Staples
- ERNA Health Care
- Exchange
- SEED Nasdaq
- ERNA Nasdaq
- Market Cap
- SEED 8.6M
- ERNA 10.2M
- IPO Year
- SEED N/A
- ERNA N/A
- Fundamental
- Price
- SEED $1.16
- ERNA $1.18
- Analyst Decision
- SEED
- ERNA
- Analyst Count
- SEED 0
- ERNA 0
- Target Price
- SEED N/A
- ERNA N/A
- AVG Volume (30 Days)
- SEED 93.0K
- ERNA 89.5K
- Earning Date
- SEED 06-26-2025
- ERNA 11-11-2025
- Dividend Yield
- SEED N/A
- ERNA N/A
- EPS Growth
- SEED N/A
- ERNA N/A
- EPS
- SEED N/A
- ERNA N/A
- Revenue
- SEED $12,910,081.00
- ERNA $488,000.00
- Revenue This Year
- SEED N/A
- ERNA N/A
- Revenue Next Year
- SEED N/A
- ERNA N/A
- P/E Ratio
- SEED N/A
- ERNA N/A
- Revenue Growth
- SEED N/A
- ERNA 201.24
- 52 Week Low
- SEED $0.74
- ERNA $1.17
- 52 Week High
- SEED $3.59
- ERNA $22.35
- Technical
- Relative Strength Index (RSI)
- SEED 55.55
- ERNA 35.05
- Support Level
- SEED $1.00
- ERNA $1.17
- Resistance Level
- SEED $1.20
- ERNA $1.57
- Average True Range (ATR)
- SEED 0.10
- ERNA 0.13
- MACD
- SEED 0.00
- ERNA 0.01
- Stochastic Oscillator
- SEED 78.12
- ERNA 2.50
About SEED Origin Agritech Limited
Origin Agritech Ltd is a Chinese agricultural technology company operating in the PRC including seed research and development activities featured in crop seed breeding and genetic improvement. The company's phytase corn was the first transgenic corn to receive the Bio-Safety Certificate from China's Ministry of Agriculture. Origin has established a robust biotechnology seed pipeline including products with glyphosate tolerance and pest resistance (Bt) traits.
About ERNA Eterna Therapeutics Inc.
Ernexa Therapeutics Inc is a biotechnology company. The company develops transformational new medicines using various cell engineering technologies for cancer and autoimmune diseases. The proprietary technology of the company transforms induced pluripotent stem cells (iPSCs) into induced mesenchymal stem cells (iMSCs), offering potential off-the-shelf treatment solutions without the need for patient-specific cell harvesting.